TrianglePUBLICATIONS · 17971487
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2008 Jan 15
- First author
- Vellenga E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Vellenga E
- type
- Author
- name
- van Putten WL
- type
- Author
- name
- van 't Veer MB
- type
- Author
- name
- Zijlstra JM
- type
- Author
- name
- Fibbe WE
- type
- Author
- name
- van Oers MH
- type
- Author
- name
- Verdonck LF
- type
- Author
- name
- Wijermans PW
- type
- Author
- name
- van Imhoff GW
- type
- Author
- name
- Lugtenburg PJ
- type
- Author
- name
- Huijgens PC
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Vellenga E
- type
- Author
- name
- van Putten WL
- type
- Author
- name
- van 't Veer MB
- type
- Author
- name
- Zijlstra JM
- type
- Author
- name
- Fibbe WE
- type
- Author
- name
- van Oers MH
- type
- Author
- name
- Verdonck LF
- type
- Author
- name
- Wijermans PW
- type
- Author
- name
- van Imhoff GW
- type
- Author
- name
- Lugtenburg PJ
- type
- Author
- name
- Huijgens PC
- type
- Author
- bibliography ids
- nci-bib-8b92c0f9d87240c607a82672
- book metadata
- content sha256
- 94d811edb83e9adf23983437bef96ff355f648f9281fd268a81c817bc886e283
- document type
- citation
- dois
- 10.1182/blood-2007-08-108415
- electronic publication date
- display
- 2007 Oct 30
- precision
- day
- year
- 2007
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17971487
- immutable id
- pubmed:17971487@94d811edb83e9adf23983437bef96ff355f648f9281fd268a81c817bc886e283
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 2
- name
- Blood
- nlm unique id
- 7603509
- pages
- 537-43
- volume
- 111
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 17971487
- provenance
- batch id
- 89a0f2206e11ca092d02
- provider
- NCBI PubMed ESummary
- record sha256
- a70296de4a3684c630e8b6f8fb9e68d09b30f13dd292dbb34daba98797aa7433
- response sha256
- 7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
- retrieved at
- 2026-09-09T23:46:16.784581+00:00
- publication date
- display
- 2008 Jan 15
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Preserved source evidence · Independent clinical review pending · Not medical advice